Lewes, DE -- (SBWIRE) -- 11/12/2014 -- The Global Cardiologist Survey is a global survey regarding end-user attitudes and perceptions towards drug-coated balloons (DCBs), transcatheter heart valve implantation (THVI) and fractional flow reserve (FFR) guidewires. Responses from interventional cardiologists from the United States and 30 other countries were gathered in person at the recent Transcatheter Cardiovascular Therapeutics (TCT) conference. Regions include South America, Europe, Asia, Middle East and North America.

Global Cardiologist Survey revealed price was the most significant consideration in product preference. The price of a DCB was considered to be one of the largest drawbacks to usage. And while this is a global trend, healthcare practitioners in Europe, Asia, Middle East and North America showed the most resistance based on product pricing.

Results also suggest a diverse coronary drug-coated balloon usage behavior. In North America 15% of respondents reported the use of drug-coated balloons in overwhelming majority of stent placement procedures. Europe’s coronary DCBs usage rate however, was surveyed to be a lot less than the similar group in North America.

Aside from price, brand preferences played a significant role in a choice-worthy DCB. The IN.PACT™ Falcon was the globally preferred DCB. In Europe, where DCBs are available, SeQuent® Please was the leading product, and in the U.S., where the devices are awaiting FDA approval, Lutonix® was the leading device that would be used, be over a third of respondents.

Global Cardiologist Survey Highlights
- The survey results revealed dramatic differences between geographical regions in usage trends
- Dominant stent type used in Europe and across the globe
- Revealed trends on procedure volumes, stent brand choice, stent length and diameter preference, types of lesions and vessels stented, preferred stent delivery type and preferred drug coating
- Revealed purchasing considerations in product preferences across the globe
- Revealed end user preference towards the use of fractional flow reserve (FFR) guidewires and most important product feature
- Revealed brand preferences for drug-coated balloons, transcatheter heart valve implantation (THVI) and fractional flow reserve (FFR) guidewires
- Global price responses by region for drug-coated balloons, transcatheter heart valve implantation (THVI) and fractional flow reserve (FFR) guidewires
- Clinical outcomes responses by region for drug-coated balloons, transcatheter heart valve implantation (THVI) and fractional flow reserve (FFR) guidewires
- Revealed number of procedures by region

Spanning over 91 pages “Global Cardiologist Physician Survey: Drug-Coated Balloons, Transcatheter Heart Valve Implantation and Fractional Flow Reserve Guidewires 2014” report covering Research Methodology, Drug-Coated Balloons, Transcatheter Heart Valve Implantation, Fractional Flow Reserve Guidewires.

Know more about this report at – http://www.marketresearchreports.com/idata-research/global-cardiologist-physician-survey-drug-coated-balloons-transcatheter-heart-valve

Find all Pharma and Healthcare Reports at: http://www.marketresearchreports.com/pharma-healthcare

About Market Research Reports, Inc.
Market Research Reports, Inc. is the world's leading source for market research reports and market data. We provide you with the latest market research reports on global markets, key industries, leading companies, new products and latest industry analysis & trends.

For regular industry updates subscribe to our newsletter at:
http://www.marketresearchreports.com/subscribe-to-newsletter